# Hoyne Bancorp, Inc.: overview

HYNE · Nasdaq · CIK 2073153 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hyne.md) · [Financials](/companies/hyne/financials.md) · [Filings](/companies/hyne/filings.md) · [Insiders](/companies/hyne/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | [(0.02)](/filings/0001104659-26-059252.md) | [0.01](/filings/0001104659-26-094047.md) |
| Free cash flow | $k | not reported | [(1,709) d](/filings/0001104659-26-035156.md) | [733](/filings/0001104659-26-059252.md) | [1,604 d](/filings/0001104659-26-094047.md) | [(2,800) d](/filings/0001104659-25-111398.md) | [665 d](/filings/0001104659-26-035156.md) | [(870)](/filings/0001104659-26-059252.md) | [(654) d](/filings/0001104659-26-094047.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: |
| Revenue | $k | not reported | not reported |
| Gross margin | % | not reported | not reported |
| Operating margin | % | not reported | not reported |
| Net margin | % | not reported | not reported |
| Diluted EPS | $ per share | not reported | [0.03](/filings/0001104659-26-035156.md) |
| Free cash flow | $k | [(3,753)](/filings/0001104659-26-035156.md) | [202](/filings/0001104659-26-035156.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hyne/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $6.1m | 367,347 |  | Reduced −2,070 |
| [FJ Capital Management LLC](/funds/1599170.md) | 2026-06-30 | $4.4m | 261,000 |  | Unchanged |
| [GRAHAM CAPITAL WEALTH MANAGEMENT, LLC](/funds/1907528.md) | 2026-06-30 | $2.9m | 175,636 |  | New +175,636 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $2.4m | 145,143 |  | Added +30,079 |
| [MANGROVE PARTNERS IM, LLC](/funds/1535392.md) | 2026-06-30 | $2.0m | 119,161 |  | Unchanged |
| [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $1.8m | 124,335 |  | Unchanged |
| [Peapod Lane Capital LLC](/funds/2050979.md) | 2026-06-30 | $1.6m | 98,232 |  | Added +1,544 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.4m | 83,078 |  | Added +1,043 |
| [Focus Partners Wealth](/funds/1542153.md) | 2026-06-30 | $1.1m | 63,400 |  | Reduced −785 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $1.0m | 60,962 |  | New +60,962 |

## Recent filings

[All 53 filings](/companies/hyne/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-11 | 16:07 ET | [10-Q](/filings/0001104659-26-094047.md) | Quarterly report, period 2026-06-30 | 0001104659-26-094047 |
| 2026-06-24 | 16:30 ET | [8-K](/filings/0001104659-26-077320.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-26-077320 |
| 2026-06-03 | 12:00 ET | [8-K](/filings/0001104659-26-069991.md) | 5.07 Shareholder vote results | 0001104659-26-069991 |
| 2026-05-12 | 13:56 ET | [10-Q](/filings/0001104659-26-059252.md) | Quarterly report, period 2026-03-31 | 0001104659-26-059252 |
| 2026-04-23 | 16:31 ET | [DEF 14A](/filings/0001104659-26-047744.md) | Proxy statement, period 2026-05-28 | 0001104659-26-047744 |
| 2026-03-26 | 16:00 ET | [10-K](/filings/0001104659-26-035156.md) | Annual report, period 2025-12-31 | 0001104659-26-035156 |
| 2025-12-03 | 17:10 ET | [8-K](/filings/0001104659-25-118175.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-118175 |
| 2025-11-28 | 10:03 ET | [8-K](/filings/0001104659-25-116727.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-116727 |
| 2025-11-14 | 16:36 ET | [8-K](/filings/0001104659-25-112641.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-112641 |
| 2025-11-13 | 16:38 ET | [10-Q](/filings/0001104659-25-111398.md) | Quarterly report, period 2025-09-30 | 0001104659-25-111398 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-035156.md), filed Mar 26, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 2073153
- Tickers: HYNE
- Exchange: Nasdaq
- SIC code: 6036 Savings Institutions, Not Federally Chartered
- State of incorporation: DE
- Filer category: Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.